by Wim Mees | Oct 23, 2019 | Team events
On October 23rd myNEO’s first teambuilding took place. The day started with a visit of Gruut, a brewery in Ghent, where we tasted some beers and where the history of the brewery was explained. Later on, we went to Cube Zero and finished an escape game in only 30...by Wim Mees | Aug 29, 2019 | Team events
On August 29th a BBQ was organised on Novalis level bringing myNEO together with the people of Biolizard and OHMX.bio. It was a great way to share experiences amongst the teams, and enjoy a nice summer breeze!The process starts with the collection of both patient blood and a tumor biopsy.
Whole-Genome Sequencing data from matched tumor and normal DNA is required for each patient.
Following alignment of these reads to the genome, somatic gene alterations in the tumor genome are detected using a collection of algorithms called 'neoX'.
Next, these somatic gene alterations are translated in-silico to obtain the tumor-specific peptides
In a last step, the peptides are prioritized using an immunogenicity predictor (neoIM) and two presentation predictors (neoMS and MHCrank).